Ainos Inc

Insightful Ainos insider buying: Chiang Yao‑Chung’s steady 129‑share purchase hints at long‑term confidence and potential valuation upside for this biotech.

TCNT’s recent Ainos share sell‑off signals tactical liquidity, not a red flag—investors should assess Ainos’ volatility and future plans before re‑valuating.